Vident Advisory’s Aehr Test Systems AEHR Stock Holding History

Vident Advisory’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$271K	Buy	+7,308	New	+$234K	﹤0.01%	1559

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vident Advisory's AEHR Position: Q1 2026 in Review

Vident Advisory opened a new position in Aehr Test Systems (AEHR) in Q1 2026: 7,308 shares worth $271K. The stake represents ﹤0.01% of the portfolio and ranks #1559 among its holdings.

191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

Vident Advisory held 7,308 shares of Aehr Test Systems worth $271K as of Q1 2026.
Aehr Test Systems was a new Vident Advisory position in Q1 2026.
Aehr Test Systems made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1559 holding.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.